RayzeBio warned of potential isotope supply issues before BMS deal
RayzeBio advised investors last year it could face problems securing actinium isotope from a Russian supplier that it relies on for international studies.
Bristol Myers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
